[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neuromodulation Devices Sales Market Report 2016

November 2016 | 108 pages | ID: G842DAD5652EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Neuromodulation Devices

Revenue, means the sales value of Neuromodulation Devices

This report studies sales (consumption) of Neuromodulation Devices in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • St. Jude Medical, Inc
  • Synapse Biomedical, Inc.
  • Nevro Corporation
  • Neurosigma, Inc.
  • Neuropace, Inc.
  • Neuronetics, Inc.
  • Cyberonics, Inc.
  • BioControl Medical
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Neuromodulation Devices in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Deep Brain Stimulation (DBS) Systems
  • Spinal Cord Stimulator (SCS) Systems
  • Diaphragm Pacing System (DPS)
  • Respiratory Electrical Stimulation (RES)
  • Vagus Nerve Stimulation (VNS)
  • Gastric Electrical Stimulation (GES)
  • Transcranial Magnetic Stimulation (TMS)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
Split by applications, this report focuses on sales, market share and growth rate of Neuromodulation Devices in each application, can be divided into
  • Chronic Pain
  • Parkinson's disease
  • Urine Incontinence
  • Epilepsy
  • Others
Global Neuromodulation Devices Sales Market Report 2016

1 NEUROMODULATION DEVICES OVERVIEW

1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Classification of Neuromodulation Devices
  1.2.1 Deep Brain Stimulation (DBS) Systems
  1.2.2 Spinal Cord Stimulator (SCS) Systems
  1.2.3 Diaphragm Pacing System (DPS)
  1.2.4 Respiratory Electrical Stimulation (RES)
  1.2.5 Vagus Nerve Stimulation (VNS)
  1.2.6 Gastric Electrical Stimulation (GES)
  1.2.7 Transcranial Magnetic Stimulation (TMS)
  1.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 Application of Neuromodulation Devices
  1.3.1 Chronic Pain
  1.3.2 Parkinson's disease
  1.3.3 Urine Incontinence
  1.3.4 Epilepsy
  1.3.5 Others
1.4 Neuromodulation Devices Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Neuromodulation Devices (2011-2021)
  1.5.1 Global Neuromodulation Devices Sales and Growth Rate (2011-2021)
  1.5.2 Global Neuromodulation Devices Revenue and Growth Rate (2011-2021)

2 GLOBAL NEUROMODULATION DEVICES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Neuromodulation Devices Market Competition by Manufacturers
  2.1.1 Global Neuromodulation Devices Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Neuromodulation Devices Revenue and Share by Manufacturers (2011-2016)
2.2 Global Neuromodulation Devices (Volume and Value) by Type
  2.2.1 Global Neuromodulation Devices Sales and Market Share by Type (2011-2016)
  2.2.2 Global Neuromodulation Devices Revenue and Market Share by Type (2011-2016)
2.3 Global Neuromodulation Devices (Volume and Value) by Regions
  2.3.1 Global Neuromodulation Devices Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Neuromodulation Devices Revenue and Market Share by Regions (2011-2016)
2.4 Global Neuromodulation Devices (Volume) by Application

3 UNITED STATES NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

3.1 United States Neuromodulation Devices Sales and Value (2011-2016)
  3.1.1 United States Neuromodulation Devices Sales and Growth Rate (2011-2016)
  3.1.2 United States Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  3.1.3 United States Neuromodulation Devices Sales Price Trend (2011-2016)
3.2 United States Neuromodulation Devices Sales and Market Share by Manufacturers
3.3 United States Neuromodulation Devices Sales and Market Share by Type
3.4 United States Neuromodulation Devices Sales and Market Share by Application

4 CHINA NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

4.1 China Neuromodulation Devices Sales and Value (2011-2016)
  4.1.1 China Neuromodulation Devices Sales and Growth Rate (2011-2016)
  4.1.2 China Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  4.1.3 China Neuromodulation Devices Sales Price Trend (2011-2016)
4.2 China Neuromodulation Devices Sales and Market Share by Manufacturers
4.3 China Neuromodulation Devices Sales and Market Share by Type
4.4 China Neuromodulation Devices Sales and Market Share by Application

5 EUROPE NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Neuromodulation Devices Sales and Value (2011-2016)
  5.1.1 Europe Neuromodulation Devices Sales and Growth Rate (2011-2016)
  5.1.2 Europe Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Neuromodulation Devices Sales Price Trend (2011-2016)
5.2 Europe Neuromodulation Devices Sales and Market Share by Manufacturers
5.3 Europe Neuromodulation Devices Sales and Market Share by Type
5.4 Europe Neuromodulation Devices Sales and Market Share by Application

6 JAPAN NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Neuromodulation Devices Sales and Value (2011-2016)
  6.1.1 Japan Neuromodulation Devices Sales and Growth Rate (2011-2016)
  6.1.2 Japan Neuromodulation Devices Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Neuromodulation Devices Sales Price Trend (2011-2016)
6.2 Japan Neuromodulation Devices Sales and Market Share by Manufacturers
6.3 Japan Neuromodulation Devices Sales and Market Share by Type
6.4 Japan Neuromodulation Devices Sales and Market Share by Application

7 GLOBAL NEUROMODULATION DEVICES MANUFACTURERS ANALYSIS

7.1 Medtronic, Inc.
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Neuromodulation Devices Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Medtronic, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Boston Scientific Corporation
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 108 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 St. Jude Medical, Inc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 122 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 St. Jude Medical, Inc Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Synapse Biomedical, Inc.
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Synapse Biomedical, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Nevro Corporation
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Nevro Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Neurosigma, Inc.
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Neurosigma, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Neuropace, Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Neuropace, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Neuronetics, Inc.
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Neuronetics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Cyberonics, Inc.
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Cyberonics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 BioControl Medical
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview

8 NEUROMODULATION DEVICES MAUFACTURING COST ANALYSIS

8.1 Neuromodulation Devices Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Neuromodulation Devices

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neuromodulation Devices Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROMODULATION DEVICES MARKET FORECAST (2016-2021)

12.1 Global Neuromodulation Devices Sales, Revenue Forecast (2016-2021)
12.2 Global Neuromodulation Devices Sales Forecast by Regions (2016-2021)
12.3 Global Neuromodulation Devices Sales Forecast by Type (2016-2021)
12.4 Global Neuromodulation Devices Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Neuromodulation Devices
Table Classification of Neuromodulation Devices
Figure Global Sales Market Share of Neuromodulation Devices by Type in 2015
Figure Deep Brain Stimulation (DBS) Systems Picture
Figure Spinal Cord Stimulator (SCS) Systems Picture
Figure Diaphragm Pacing System (DPS) Picture
Figure Respiratory Electrical Stimulation (RES) Picture
Figure Vagus Nerve Stimulation (VNS) Picture
Figure Gastric Electrical Stimulation (GES) Picture
Figure Transcranial Magnetic Stimulation (TMS) Picture
Figure Transcutaneous Electrical Nerve Stimulation (TENS) Picture
Table Applications of Neuromodulation Devices
Figure Global Sales Market Share of Neuromodulation Devices by Application in 2015
Figure Chronic Pain Examples
Figure Parkinson's disease Examples
Figure Urine Incontinence Examples
Figure Epilepsy Examples
Figure Others Examples
Figure United States Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure China Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Europe Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Japan Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Figure Global Neuromodulation Devices Sales and Growth Rate (2011-2021)
Figure Global Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Table Global Neuromodulation Devices Sales of Key Manufacturers (2011-2016)
Table Global Neuromodulation Devices Sales Share by Manufacturers (2011-2016)
Figure 2015 Neuromodulation Devices Sales Share by Manufacturers
Figure 2016 Neuromodulation Devices Sales Share by Manufacturers
Table Global Neuromodulation Devices Revenue by Manufacturers (2011-2016)
Table Global Neuromodulation Devices Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Neuromodulation Devices Revenue Share by Manufacturers
Table 2016 Global Neuromodulation Devices Revenue Share by Manufacturers
Table Global Neuromodulation Devices Sales and Market Share by Type (2011-2016)
Table Global Neuromodulation Devices Sales Share by Type (2011-2016)
Figure Sales Market Share of Neuromodulation Devices by Type (2011-2016)
Figure Global Neuromodulation Devices Sales Growth Rate by Type (2011-2016)
Table Global Neuromodulation Devices Revenue and Market Share by Type (2011-2016)
Table Global Neuromodulation Devices Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neuromodulation Devices by Type (2011-2016)
Figure Global Neuromodulation Devices Revenue Growth Rate by Type (2011-2016)
Table Global Neuromodulation Devices Sales and Market Share by Regions (2011-2016)
Table Global Neuromodulation Devices Sales Share by Regions (2011-2016)
Figure Sales Market Share of Neuromodulation Devices by Regions (2011-2016)
Figure Global Neuromodulation Devices Sales Growth Rate by Regions (2011-2016)
Table Global Neuromodulation Devices Revenue and Market Share by Regions (2011-2016)
Table Global Neuromodulation Devices Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Neuromodulation Devices by Regions (2011-2016)
Figure Global Neuromodulation Devices Revenue Growth Rate by Regions (2011-2016)
Table Global Neuromodulation Devices Sales and Market Share by Application (2011-2016)
Table Global Neuromodulation Devices Sales Share by Application (2011-2016)
Figure Sales Market Share of Neuromodulation Devices by Application (2011-2016)
Figure Global Neuromodulation Devices Sales Growth Rate by Application (2011-2016)
Figure United States Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure United States Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure United States Neuromodulation Devices Sales Price Trend (2011-2016)
Table United States Neuromodulation Devices Sales by Manufacturers (2011-2016)
Table United States Neuromodulation Devices Market Share by Manufacturers (2011-2016)
Table United States Neuromodulation Devices Sales by Type (2011-2016)
Table United States Neuromodulation Devices Market Share by Type (2011-2016)
Table United States Neuromodulation Devices Sales by Application (2011-2016)
Table United States Neuromodulation Devices Market Share by Application (2011-2016)
Figure China Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure China Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure China Neuromodulation Devices Sales Price Trend (2011-2016)
Table China Neuromodulation Devices Sales by Manufacturers (2011-2016)
Table China Neuromodulation Devices Market Share by Manufacturers (2011-2016)
Table China Neuromodulation Devices Sales by Type (2011-2016)
Table China Neuromodulation Devices Market Share by Type (2011-2016)
Table China Neuromodulation Devices Sales by Application (2011-2016)
Table China Neuromodulation Devices Market Share by Application (2011-2016)
Figure Europe Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Europe Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Europe Neuromodulation Devices Sales Price Trend (2011-2016)
Table Europe Neuromodulation Devices Sales by Manufacturers (2011-2016)
Table Europe Neuromodulation Devices Market Share by Manufacturers (2011-2016)
Table Europe Neuromodulation Devices Sales by Type (2011-2016)
Table Europe Neuromodulation Devices Market Share by Type (2011-2016)
Table Europe Neuromodulation Devices Sales by Application (2011-2016)
Table Europe Neuromodulation Devices Market Share by Application (2011-2016)
Figure Japan Neuromodulation Devices Sales and Growth Rate (2011-2016)
Figure Japan Neuromodulation Devices Revenue and Growth Rate (2011-2016)
Figure Japan Neuromodulation Devices Sales Price Trend (2011-2016)
Table Japan Neuromodulation Devices Sales by Manufacturers (2011-2016)
Table Japan Neuromodulation Devices Market Share by Manufacturers (2011-2016)
Table Japan Neuromodulation Devices Sales by Type (2011-2016)
Table Japan Neuromodulation Devices Market Share by Type (2011-2016)
Table Japan Neuromodulation Devices Sales by Application (2011-2016)
Table Japan Neuromodulation Devices Market Share by Application (2011-2016)
Table Medtronic, Inc. Basic Information List
Table Medtronic, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medtronic, Inc. Neuromodulation Devices Global Market Share (2011-2016)
Table Boston Scientific Corporation Basic Information List
Table Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boston Scientific Corporation Neuromodulation Devices Global Market Share (2011-2016)
Table St. Jude Medical, Inc Basic Information List
Table St. Jude Medical, Inc Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure St. Jude Medical, Inc Neuromodulation Devices Global Market Share (2011-2016)
Table Synapse Biomedical, Inc. Basic Information List
Table Synapse Biomedical, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Synapse Biomedical, Inc. Neuromodulation Devices Global Market Share (2011-2016)
Table Nevro Corporation Basic Information List
Table Nevro Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Nevro Corporation Neuromodulation Devices Global Market Share (2011-2016)
Table Neurosigma, Inc. Basic Information List
Table Neurosigma, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neurosigma, Inc. Neuromodulation Devices Global Market Share (2011-2016)
Table Neuropace, Inc. Basic Information List
Table Neuropace, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neuropace, Inc. Neuromodulation Devices Global Market Share (2011-2016)
Table Neuronetics, Inc. Basic Information List
Table Neuronetics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Neuronetics, Inc. Neuromodulation Devices Global Market Share (2011-2016)
Table Cyberonics, Inc. Basic Information List
Table Cyberonics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cyberonics, Inc. Neuromodulation Devices Global Market Share (2011-2016)
Table BioControl Medical Basic Information List
Table BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BioControl Medical Neuromodulation Devices Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromodulation Devices
Figure Manufacturing Process Analysis of Neuromodulation Devices
Figure Neuromodulation Devices Industrial Chain Analysis
Table Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2015
Table Major Buyers of Neuromodulation Devices
Table Distributors/Traders List
Figure Global Neuromodulation Devices Sales and Growth Rate Forecast (2016-2021)
Figure Global Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Table Global Neuromodulation Devices Sales Forecast by Regions (2016-2021)
Table Global Neuromodulation Devices Sales Forecast by Type (2016-2021)
Table Global Neuromodulation Devices Sales Forecast by Application (2016-2021)


More Publications